Top of this page
Skip navigation, go straight to the content
Welcome to UCB Investor Relations
Our Investor Relations team aim to serve analysts, shareholders and potential investors with timely, valuable and reliable information.
Annual report 2009
CSR report 2009
News List ›
- E Keppra (levetiracetam) receives regulatory approval in Japan 23-Jul-2010
- UCB strengthens ICT department to foster its transformation into a global patient centric biopharma leader 19-Jul-2010
- UCB strengthens strategic alliance with WILEX 09-Jun-2010
- UCB's Roch Doliveux joins Board of the Innovative Medicines Initiative 17-May-2010
More information
Quick access
Upcoming events
| Date | Event details |
|---|---|
| 02 Aug 2010 | |
| 21 Oct 2010 |
